camptothecin has been researched along with Chordoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baker, LH; Biermann, JS; Chandler, WF; Chugh, R; Dunn, R; Leu, KM; Mace, JR; Sondak, VK; Zalupski, MM | 1 |
1 trial(s) available for camptothecin and Chordoma
Article | Year |
---|---|
Phase II study of 9-nitro-camptothecin in patients with advanced chordoma or soft tissue sarcoma.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Chordoma; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Probability; Risk Assessment; Sarcoma; Soft Tissue Neoplasms; Survival Analysis; Treatment Outcome | 2005 |